As UC Irvine Douglas Hospital prepared to open its doors to patients in March 2009, caregivers discussed how the new facility strengthens their ability to provide advanced healthcare. From larger operating rooms equipped with the latest technology to a meditation/prayer room that offers a soothing refuge for families and visitors, UC Irvine Douglas Hospital is […]
The state today tentatively approved $3.3 million over three years to enhance UC Irvine’s stem cell training program, which teaches tomorrow’s experts the techniques, ethics and clinical knowledge critical to this fast-growing field.
Barack Obama swept into the presidency on a platform of change, one that includes a number of scientific policy and research issues. As a major research university, UC Irvine is deeply involved in some of these key areas – stem cells, global warming and alternative energy, to name a few. Research vice chancellor Susan Bryant discusses how changes made in Washington, D.C., and Sacramento, especially during the current economic crisis, will impact research efforts at UCI.
The March 2009 opening of UC Irvine’s University Hospital heralds a new chapter in healthcare for the people of Orange County.
A therapy developed at UC Irvine that made paralyzed rats walk again will become the world’s first embryonic stem cell treatment tested in humans.
Professor Hongkai Zhao uses mathematics to make computers run better, which in turn improves medical imaging and engineering design.
As a brain imaging researcher who studies schizophrenia, Dr. Steven Potkin saw a large problem limiting growth in his field and the potential for new clinical treatments.
Women who smoke are three times more likely to develop cervical cancer, and UC Irvine scientists recently discovered the biological link.
Neurobiologist Frank LaFerla is taking the reins of the UC Irvine Institute for Brain Aging & Dementia, hoping to boost clinical offerings and move forward with a new building dedicated to Alzheimer’s disease research.
As an anesthesiologist, UC Irvine’s Dr. Michael Alkire wants to tackle what many neuroscientists see as the Holy Grail of their field – the biological basis of consciousness.